TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ESLA

Estrella Immunopharma Inc.

Healthcare · Biotechnology

0.529$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ESLA
Line item 2020 2021 2022 2023 2024 2025
+203.8% +652.4% -60.7% +56.0% +59.9%
+7.2% +123.9% +382.7% -23.9% +15.5%
+129.7% +559.5% -34.2% +21.0% +47.7%
-50.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?